These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9842280)

  • 1. [Efficacy and efficiency of antitubercular treatment in health jurisdictions of Morelos].
    García-García ML; Mayar-Maya ME; Ferreyra-Reyes L; Palacios-Martínez M; Alvarez-García C; Valdespino-Gómez JL
    Salud Publica Mex; 1998; 40(5):421-9. PubMed ID: 9842280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug resistance of Mycobacterium tuberculosis in Orizaba, Veracruz. Implications for the tuberculosis prevention and control program].
    García-García ML; Sifuentes-Osornio J; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Bobadilla-del Valle M; Palacios-Martínez M; Canales G; Sanginés A; Jaramillo Y; Martínez-Gamboa A; Balandrano S; Valdespino-Gómez JL; Small P
    Rev Invest Clin; 2001; 53(4):315-23. PubMed ID: 11599478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological analysis of tuberculosis treatment outcome as a tool for changing TB control policy in Israel.
    Chemtob D; Epstein L; Slater PE; Weiler-Ravell D
    Isr Med Assoc J; 2001 Jul; 3(7):479-83. PubMed ID: 11791411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of and factors for non-compliance to antituberculous treatment].
    Cáceres Fde M; Orozco LC
    Biomedica; 2007 Dec; 27(4):498-504. PubMed ID: 18320117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of shortened directly observed treatment on compliance and cure rate of pulmonary tuberculosis].
    Martínez-Medina MA
    Gac Med Mex; 2004; 140(1):1-6. PubMed ID: 15022881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low failure rate in standardised retreatment of tuberculosis in Nicaragua: patient category, drug resistance and survival of 'chronic' patients.
    Heldal E; Arnadottir T; Cruz JR; Tardencilla A; Chacon L
    Int J Tuberc Lung Dis; 2001 Feb; 5(2):129-36. PubMed ID: 11258506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico.
    Nájera-Ortiz JC; Sánchez-Pérez HJ; Ochoa-Díaz H; Arana-Cedeño M; Lezama MS; Mateo MM
    Int J Epidemiol; 2008 Aug; 37(4):786-95. PubMed ID: 18511492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru.
    Chavez Pachas AM; Blank R; Smith Fawzi MC; Bayona J; Becerra MC; Mitnick CD
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):52-8. PubMed ID: 14974746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of tuberculosis in a rural area of Haiti: directly observed and non-observed regimens. The experience of H pital Albert Schweitzer.
    Ollé-Goig JE; Alvarez J
    Int J Tuberc Lung Dis; 2001 Feb; 5(2):137-41. PubMed ID: 11258507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally.
    Radilla-Chávez P; Laniado-Laborín R
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):289-92. PubMed ID: 17352094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis drug resistance in a suburban community in southern Mexico.
    García-García ML; Jiménez-Corona ME; Ponce-de-León A; Jiménez-Corona A; Palacios-Martínez M; Balandrano-Campos S; Ferreyra-Reyes L; Juárez-Sandino L; Sifuentes-Osornio J; Olivera-Díaz H; Valdespino-Gómez JL; Small PM
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S168-70. PubMed ID: 11144548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
    Sharma S; Sarin R; Khalid UK; Singla N; Sharma PP; Behera D
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):74-80. PubMed ID: 18173881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experiences of a community-based tuberculosis treatment programme in Namibia: a comparative cohort study.
    Zvavamwe Z; Ehlers VJ
    Int J Nurs Stud; 2009 Mar; 46(3):302-9. PubMed ID: 18995854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting non-completion of tuberculosis treatment among HIV-infected patients in Barcelona (1987-1996).
    Tangüis HG; Caylà JA; García de Olalla PG; Jansà JM; Brugal MT
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):55-60. PubMed ID: 10654645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000.
    Ormerod LP; Horsfield N; Green RM
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):662-5. PubMed ID: 12150476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dynamics of pulmonary tuberculosis in Colima, Mexico (1999-2002).
    Chowell G; Diaz-Dueñas P; Chowell D
    Scand J Infect Dis; 2005; 37(11-12):858-62. PubMed ID: 16308221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000.
    Santha T; Garg R; Frieden TR; Chandrasekaran V; Subramani R; Gopi PG; Selvakumar N; Ganapathy S; Charles N; Rajamma J; Narayanan PR
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):780-8. PubMed ID: 12234133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOT or not? Direct observation of anti-tuberculosis treatment and patient outcomes, Kerala State, India.
    Balasubramanian VN; Oommen K; Samuel R
    Int J Tuberc Lung Dis; 2000 May; 4(5):409-13. PubMed ID: 10815733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.